BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdellatif KR, Belal A, El-saadi MT, Amin NH, Said EG, Hemeda LR. Design, synthesis, molecular docking and antiproliferative activity of some novel benzothiazole derivatives targeting EGFR/HER2 and TS. Bioorganic Chemistry 2020;101:103976. [DOI: 10.1016/j.bioorg.2020.103976] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 El‐mekabaty A, Sofan MA, Hasel AM, Said SB. Concise Synthesis of Some New Benzothiazole‐Based Heterocycles as Probable Anticancer and Antioxidant Agents. ChemistrySelect 2021;6:2569-75. [DOI: 10.1002/slct.202100372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sharma B, Singh VJ, Chawla PA. Epidermal growth factor receptor inhibitors as potential anticancer agents: An update of recent progress. Bioorg Chem 2021;116:105393. [PMID: 34628226 DOI: 10.1016/j.bioorg.2021.105393] [Reference Citation Analysis]
3 Kalal P, Sethiya A, Soni J, Patel I, Gandhi D, Agarwal S. Caffeine hydrogen sulfate: a recyclable solid acid catalyst for mechanochemical synthesis of 2-arylbenzothiazoles. Journal of Sulfur Chemistry. [DOI: 10.1080/17415993.2021.2010278] [Reference Citation Analysis]
4 Amin NH, El-Saadi MT, Ibrahim AA, Abdel-Rahman HM. Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents. Bioorg Chem 2021;111:104841. [PMID: 33798851 DOI: 10.1016/j.bioorg.2021.104841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 El-meguid EAA, Moustafa GO, Awad HM, Zaki ER, Nossier ES. Novel benzothiazole hybrids targeting EGFR: Design, synthesis, biological evaluation and molecular docking studies. Journal of Molecular Structure 2021;1240:130595. [DOI: 10.1016/j.molstruc.2021.130595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Sethiya A, Sahiba N, Teli P, Soni J, Agarwal S. Current advances in the synthetic strategies of 2-arylbenzothiazole. Mol Divers 2020. [PMID: 33180241 DOI: 10.1007/s11030-020-10149-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sibuh BZ, Khanna S, Taneja P, Sarkar P, Taneja NK. Molecular docking, synthesis and anticancer activity of thiosemicarbazone derivatives against MCF-7 human breast cancer cell line. Life Sci 2021;273:119305. [PMID: 33675898 DOI: 10.1016/j.lfs.2021.119305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Haider K, Rehman S, Pathak A, Najmi AK, Yar MS. Advances in 2-substituted benzothiazole scaffold-based chemotherapeutic agents. Arch Pharm (Weinheim) 2021;:e2100246. [PMID: 34467567 DOI: 10.1002/ardp.202100246] [Reference Citation Analysis]
9 Ngoc Toan V, Dinh Thanh N, Minh Tri N. 1,3,4-Thiadiazoline−coumarin hybrid compounds containing D-glucose/D-galactose moieties: Synthesis and evaluation of their antiproliferative activity. Arabian Journal of Chemistry 2021;14:103053. [DOI: 10.1016/j.arabjc.2021.103053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]